17 September 2008

MEDICINES

Impact assessment of the introduction of a statutory scheme to control the prices of branded NHS medicines (5th September 2008)
The Government is seeking to agree a new voluntary, non-contractual scheme to replace the Pharmaceutical Price Regulation Scheme. The objective of a statutory scheme is to safeguard the financial position of the NHS in the event that companies do not sign up to the new voluntary pricing scheme or in case of failure to reach agreement on a new voluntary pricing scheme.
Impact Assessment

No comments: